| Product NDC: | 57664-357 |
| Proprietary Name: | FLUVOXAMINE MALEATE |
| Non Proprietary Name: | fluvoxamine maleate |
| Active Ingredient(s): | 25 mg/1 & nbsp; fluvoxamine maleate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 57664-357 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075900 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060223 |
| Package NDC: | 57664-357-88 |
| Package Description: | 100 TABLET in 1 BOTTLE (57664-357-88) |
| NDC Code | 57664-357-88 |
| Proprietary Name | FLUVOXAMINE MALEATE |
| Package Description | 100 TABLET in 1 BOTTLE (57664-357-88) |
| Product NDC | 57664-357 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fluvoxamine maleate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20060223 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | FLUVOXAMINE MALEATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |